Due to network maintenance at the University of Basel, the SWISS-MODEL website will be interrupted this weekend between 07:00 CET Saturday 17th May and 23:55 CET Sunday 18th May.

Multiple Assemblies exist for SMTL entry 5i5k
Structure of complement C5 in complex with eculizumab; X-RAY DIFFRACTION 4.20 Å

SMTL ID
5i5k.1
Ligands
beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
Polypeptides
Complement C5; Eculizumab heavy chain (variable domain); Eculizumab light chain (variable domain)
Oligo-state
hetero-1-1-1-mer
SMTL ID
5i5k.2
Ligands
beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
Polypeptides
Complement C5; Eculizumab heavy chain (variable domain); Eculizumab light chain (variable domain)
Oligo-state
hetero-1-1-1-mer